These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29049013)

  • 61. MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
    Yan S; Jiang H; Fang S; Yin F; Wang Z; Jia Y; Sun X; Wu S; Jiang T; Mao A
    Cell Physiol Biochem; 2015; 37(1):375-86. PubMed ID: 26316084
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression.
    Feng F; Qiu B; Zang R; Song P; Gao S
    Oncotarget; 2017 Apr; 8(17):29091-29100. PubMed ID: 28404970
    [TBL] [Abstract][Full Text] [Related]  

  • 63. miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.
    Nie J; Ge X; Geng Y; Cao H; Zhu W; Jiao Y; Wu J; Zhou J; Cao J
    Oncol Rep; 2015 Jul; 34(1):311-7. PubMed ID: 25954903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.
    Osako Y; Seki N; Kita Y; Yonemori K; Koshizuka K; Kurozumi A; Omoto I; Sasaki K; Uchikado Y; Kurahara H; Maemura K; Natsugoe S
    Int J Oncol; 2016 Dec; 49(6):2255-2264. PubMed ID: 27779648
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
    Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
    World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting SMAD2.
    Liu L; Zhao Z; Zhou W; Fan X; Zhan Q; Song Y
    J Genet Genomics; 2015 Nov; 42(11):601-611. PubMed ID: 26674378
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integrative genomics unveils basement membrane-related diagnostic markers and therapeutic targets in esophageal squamous cell carcinoma.
    Zhang H; Zhang X; Huang Z; Zhang H
    Biol Direct; 2024 Sep; 19(1):79. PubMed ID: 39256753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
    Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
    Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.
    Qiu YT; Wang WJ; Zhang B; Mei LL; Shi ZZ
    Oncol Rep; 2017 Jun; 37(6):3590-3596. PubMed ID: 28498460
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of protein expression pattern of stanniocalcin 2, insulin-like growth factor-binding protein 7, inhibin beta A and four and a half LIM domains 1 in esophageal squamous cell carcinoma.
    Kashyap MK; Pawar HA; Keerthikumar S; Sharma J; Goel R; Mahmood R; Kumar MV; Kumar KV; Pandey A; Kumar RV; Prasad TS; Harsha HC
    Cancer Biomark; 2012-2013; 12(1):1-9. PubMed ID: 23321464
    [TBL] [Abstract][Full Text] [Related]  

  • 72. LAMC1 upregulation via TGFβ induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-κB-CXCL1-STAT3.
    Fang L; Che Y; Zhang C; Huang J; Lei Y; Lu Z; Sun N; He J
    Mol Oncol; 2021 Nov; 15(11):3125-3146. PubMed ID: 34218518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of a novel fusion gene (HLA-E and HLA-B) by RNA-seq analysis in esophageal squamous cell carcinoma.
    Jiang YZ; Li QH; Zhao JQ; Lv JJ
    Asian Pac J Cancer Prev; 2014; 15(5):2309-12. PubMed ID: 24716975
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.
    Couch G; Redman JE; Wernisch L; Newton R; Malhotra S; Dawsey SM; Lao-Sirieix P; Fitzgerald RC
    Cancer Prev Res (Phila); 2016 Jul; 9(7):558-66. PubMed ID: 27072986
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
    Tungekar A; Mandarthi S; Mandaviya PR; Gadekar VP; Tantry A; Kotian S; Reddy J; Prabha D; Bhat S; Sahay S; Mascarenhas R; Badkillaya RR; Nagasampige MK; Yelnadu M; Pawar H; Hebbar P; Kashyap MK
    Sci Rep; 2018 Aug; 8(1):12715. PubMed ID: 30143675
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.
    Hu N; Kadota M; Liu H; Abnet CC; Su H; Wu H; Freedman ND; Yang HH; Wang C; Yan C; Wang L; Gere S; Hutchinson A; Song G; Wang Y; Ding T; Qiao YL; Koshiol J; Dawsey SM; Giffen C; Goldstein AM; Taylor PR; Lee MP
    Cancer Res; 2016 Apr; 76(7):1714-23. PubMed ID: 26857264
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa.
    Van Loon K; Mmbaga EJ; Mushi BP; Selekwa M; Mwanga A; Akoko LO; Mwaiselage J; Mosha I; Ng DL; Wu W; Silverstein J; Mulima G; Kaimila B; Gopal S; Snell JM; Benz SC; Vaske C; Sanborn Z; Sedgewick AJ; Radenbaugh A; Newton Y; Collisson EA
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1411-1420. PubMed ID: 37505926
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.
    Zhang C; Fu L; Fu J; Hu L; Yang H; Rong TH; Li Y; Liu H; Fu SB; Zeng YX; Guan XY
    Clin Cancer Res; 2009 Jun; 15(12):4017-27. PubMed ID: 19509166
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential Protein Interactome in Esophageal Squamous Cell Carcinoma Offers Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance.
    Gulfidan G; Beklen H; Sinha I; Kucukalp F; Caloglu B; Esen I; Turanli B; Ayyildiz D; Arga KY; Sinha R
    OMICS; 2021 Aug; 25(8):495-512. PubMed ID: 34297901
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma.
    Abboud HS; Camuzi D; Rapozo DC; Fernandes PV; Nicolau-Neto P; Guaraldi S; Simão TA; Ribeiro Pinto LF; Gonzaga IM; Soares-Lima SC
    Braz J Med Biol Res; 2021; 54(8):e10877. PubMed ID: 34037097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.